Filter:
For Immediate Release April 1, 2020 -Alphas on Medicare have a new Choice! The Centers for Medicare and Medicaid […]
March 24, 2020 The American Plasma Users Coalition (APLUS) appreciates the current efforts of your agency to protect public health […]
Read More… from APLUS Supports Plasma Donor Recognition & Home Infusion
In light of the Public Health Emergency concerning the coronavirus disease 2019 (COVID-19), the Office for Civil Rights (OCR) at […]
Read More… from BULLETIN: Civil Rights, HIPAA, and the Coronavirus Disease 2019 (COVID-19)
As a global pharmaceutical leader, we are doing all we can to protect the health of our employees, their families […]
A team of more than 50 volunteers at the Center for Regenerative Medicine (CReM) on Boston University’s Medical Campus, directed by Alpha doctor, […]
March 26, 2020 Early this morning, the Senate passed a $2 trillion COVID-19 relief bill. The Bill (S. 3548) is […]
Read More… from CARES ACT Bill (S.3548) passed by The Senate
Barcelona, March 25, 2020 – Grifols today announces that it has entered into a formal collaboration with the United States […]
Because of COVID-19’s impacts on the lungs, the U.S. Alpha-1 Foundation has provided detailed, specific guidance for patients who have alpha […]
Read More… from Coronavirus: Alpha 1 Group Gives Specific Guidance for Patients
This coalition waiver request adds three additional options for physicians and home health agencies as they endeavor to keep those with […]
CSL continues to provide medicines to patients around the world. Safeguarding our people, patients and donors remains our top priority. […]
Read More… from COVID-19: CSL continues to provide medicines to patients around the world.
STATEMENT UPDATED: March 18, 2020 It is our commitment to provide you with updated guidelines on COVID-19, please find the […]
Read More… from WEDNESDAY, MARCH 18 COVID-19 Update from the Alpha-1 Foundation & AlphaNet
Shortly after the FDA granted an Emergency Use Authorization to its first commercially developed coronavirus test—developed by Roche for use […]
For many immunocompromised people, social distancing isn’t a new endeavor. Alpha-1 Antitrypsin Deficiency is sometimes called an “invisible disability”. This […]
STATEMENT UPDATED: March 12, 2020 Please note, this statement is specific to the United States. If you are an individual […]
Read More… from THURSDAY, MARCH 12 COVID-19 Update from the Alpha-1 Foundation & AlphaNet
STATEMENT UPDATED: March 9, 2020 Please note, this statement is specific to the United States. If you are an individual […]
Read More… from COVID-19 Update from the Alpha-1 Foundation & AlphaNet
As the situation with the novel coronavirus rapidly evolves, we wanted to inform you that Grifols is taking measures in […]
Read More… from Grifols Update Regarding the Novel Coronavirus
March 4, 2020- The 2020 Celtic Connection will take place this Saturday, March 7th at the Boston Marriott Newton to […]
Read More… from Don’t be green with envy… Join us this Saturday for the 2020 Celtic Connection
STATEMENT UPDATED: March 2, 2020 The current outbreak of 2019 novel coronavirus (COVID-19) was first identified in China but has […]
Read More… from Update on 2019 novel coronavirus from the Alpha-1 Foundation & AlphaNet
WHO: The Alpha-1 Community! Every Alpha, family member, caregiver, friend, healthcare professional researcher and industry member can participate. The Alpha-1 […]
https://www.alpha1.org/alphas-friends-family/resources/clinical-trials/ A clinical trial is a research study in which one or more human subjects are prospectively assigned to one […]
Recent international reports have highlighted the emergence of a new coronavirus in Wuhan, Hubei Province, China. The 2019 Novel Coronavirus […]
Read More… from 2019 Novel Coronavirus (2019-nCoV) and Plasma Protein Therapies
Miami, January 31, 2020 – The Alpha-1 Foundation is proud to celebrate its 25th Anniversary. On January 31, 1995, the […]
Read More… from The Alpha-1 Foundation celebrates its 25th anniversary
The Alpha-1 Foundation is proud to report that multinational pharmaceutical manufacturer Grifols also received approval by the Danish Medicines Council […]
Read More… from Grifols’s Prolastina approved for use in Denmark
Blood products and vaccines specialist CSL Behring announced that the Danish Medicines Council has published its final decision, approving human […]
Read More… from CSL Behring’s Respreeza gains approval in Denmark
